RPX Corp  

(Public, NASDAQ:RPXC)   Watch this stock  
Find more results for RPXC
10.07
+0.01 (0.10%)
Jul 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.96 - 10.15
52 week 8.60 - 15.66
Open 10.09
Vol / Avg. 311,444.00/316,295.00
Mkt cap 503.19M
P/E 21.62
Div/yield     -
EPS 0.47
Shares 51.37M
Beta 1.15
Inst. own 91%
Aug 2, 2016
Q2 2016 RPX Corp Earnings Call - 5:00PM EDT - Add to calendar
Aug 2, 2016
Q2 2016 RPX Corp Earnings Release - 4:00PM EDT - Add to calendar
Jul 8, 2016
RPX Corp Annual Shareholders Meeting
Jun 8, 2016
RPX Corp Annual Shareholders Meeting (Estimated)
Jun 8, 2016
RPX Corp at Robert W Baird Global Consumer, Technology & Services Conference
Jun 1, 2016
RPX Corp at Cowen Technology, Media & Telecom Conference
May 3, 2016
Q1 2016 RPX Corp Earnings Call
May 3, 2016
Q1 2016 RPX Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 5.31% 13.51%
Operating margin 6.49% 22.68%
EBITD margin - 72.44%
Return on average assets 2.38% 6.06%
Return on average equity 3.34% 7.87%
Employees 161 -
CDP Score - -

Address

1 Market Plz
SAN FRANCISCO, CA 94105-1101
United States - Map
+1-866-7797641 (Phone)
+1-302-5313150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

RPX Corporation offers patent risk management solutions. The Company's patent risk management solution facilitates exchanges of value between owners and users of patents. The core of its solution is defensive patent aggregation, in which the Company acquires patents and licenses to patents that are being or may be asserted against its clients. The Company then licenses these patent assets to its clients to protect them from patent infringement assertions. The Company also provides its clients with access to its patent market intelligence and data. The Company acquires patent assets from various parties, including operating companies, individual inventors, non-practicing entities (NPEs), universities and bankruptcy trustees. Clients can access this market intelligence and data through its Web portal and through discussions with its client relations team. The Company also offers insurance to cover certain costs of patent litigation.

Officers and directors

John A. Amster J.D. President, Chief Executive Officer, Director
Age: 46
Bio & Compensation  - Reuters
Robert H. Heath Chief Financial Officer, Senior Vice President - Finance, Treasurer
Age: 55
Bio & Compensation  - Reuters
Mallun Yen J.D. Executive Vice President
Age: 44
Bio & Compensation  - Reuters
Martin E. Roberts Jr. Senior Vice President, General Counsel, Secretary
Age: 54
Bio & Compensation  - Reuters
Steven S. Swank Senior Vice President - Head of Client Development and Relations
Age: 45
Bio & Compensation  - Reuters
Thomas O. Ryder Lead Independent Director
Age: 71
Bio & Compensation  - Reuters
Gilbert Samuel Palter Director
Age: 50
Bio & Compensation  - Reuters
Andrew D. Africk Independent Director
Age: 46
Bio & Compensation  - Reuters
Shelby W. Bonnie Independent Director
Age: 50
Bio & Compensation  - Reuters
Frank E. Dangeard Independent Director
Age: 58
Bio & Compensation  - Reuters